CetuGEX: Phase I started

Glycotope began a Phase I trial of CetuGEX in about 60 patients. Erbitux is marketed by ImClone Systems Inc., a subsidiary of Eli Lilly and Co. (NYSE:LLY, Indianapolis, Ind.) and Bristol-Myers Squi...